Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Clinical and molecular approaches to individualize antihypertensive drug therapy.

Hiltunen TP, Kontula K.

Ann Med. 2012 Jun;44 Suppl 1:S23-9. doi: 10.3109/07853890.2012.679960. Review.

PMID:
22713145
2.

Predictors of antihypertensive drug responses: initial data from a placebo-controlled, randomized, cross-over study with four antihypertensive drugs (The GENRES Study).

Hiltunen TP, Suonsyrjä T, Hannila-Handelberg T, Paavonen KJ, Miettinen HE, Strandberg T, Tikkanen I, Tilvis R, Pentikäinen PJ, Virolainen J, Kontula K.

Am J Hypertens. 2007 Mar;20(3):311-8.

PMID:
17324745
3.

Laboratory tests as predictors of the antihypertensive effects of amlodipine, bisoprolol, hydrochlorothiazide and losartan in men: results from the randomized, double-blind, crossover GENRES Study.

Suonsyrjä T, Hannila-Handelberg T, Paavonen KJ, Miettinen HE, Donner K, Strandberg T, Tikkanen I, Tilvis R, Pentikäinen PJ, Kontula K, Hiltunen TP.

J Hypertens. 2008 Jun;26(6):1250-6. doi: 10.1097/HJH.0b013e3282fcc37f.

PMID:
18475165
4.

Pharmacogenetics of antihypertensive treatment.

Arnett DK, Claas SA, Glasser SP.

Vascul Pharmacol. 2006 Feb;44(2):107-18. Epub 2005 Dec 13. Review.

PMID:
16356784
5.

STK39 variation predicts the ambulatory blood pressure response to losartan in hypertensive men.

Donner KM, Hiltunen TP, Hannila-Handelberg T, Suonsyrjä T, Kontula K.

Hypertens Res. 2012 Jan;35(1):107-14. doi: 10.1038/hr.2011.166. Epub 2011 Oct 13.

PMID:
21993215
6.

Pharmacogenetics of antihypertensive drug responses.

Schwartz GL, Turner ST.

Am J Pharmacogenomics. 2004;4(3):151-60. Review.

PMID:
15174896
7.
8.

Are there benefits to specific antihypertensive drug therapy?

Cushman WC.

Am J Hypertens. 2003 Nov;16(11 Pt 2):31S-35S. Review.

PMID:
14625158
9.

The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension.

Thomas GN, Chan P, Tomlinson B.

Drugs Aging. 2006;23(2):131-55. Review.

PMID:
16536636
10.

Efficacy and tolerability of nebivolol compared with other antihypertensive drugs: a meta-analysis.

Van Bortel LM, Fici F, Mascagni F.

Am J Cardiovasc Drugs. 2008;8(1):35-44.

PMID:
18303936
11.

Pharmacogenomics of hypertension: a genome‐wide, placebo‐controlled cross‐over study, using four classes of antihypertensive drugs.

Hiltunen TP, Donner KM, Sarin AP, Saarela J, Ripatti S, Chapman AB, Gums JG, Gong Y, Cooper-DeHoff RM, Frau F, Glorioso V, Zaninello R, Salvi E, Glorioso N, Boerwinkle E, Turner ST, Johnson JA, Kontula KK.

J Am Heart Assoc. 2015 Jan 26;4(1):e001521. doi: 10.1161/JAHA.115.001778.

12.

Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management.

Petrella R, Michailidis P.

Clin Ther. 2011 Sep;33(9):1190-203. doi: 10.1016/j.clinthera.2011.08.008. Epub 2011 Sep 1.

PMID:
21885126
13.

Issues in drug metabolism of major antihypertensive drugs: beta-blockers, calcium channel antagonists and angiotensin receptor blockers.

Höcht C, Bertera FM, Mayer MA, Taira CA.

Expert Opin Drug Metab Toxicol. 2010 Feb;6(2):199-211. doi: 10.1517/17425250903397381. Review.

PMID:
20095790
14.

Efficacy of fixed-dose combination therapy in the treatment of patients with hypertension: focus on amlodipine/valsartan.

da Silva PM.

Clin Drug Investig. 2010;30(9):625-41. doi: 10.2165/11538440-000000000-00000. Review.

PMID:
20626210
15.

Gene markers and antihypertensive therapy.

Turner ST, Schwartz GL.

Curr Hypertens Rep. 2005 Feb;7(1):21-30. Review.

PMID:
15683583
16.

The effects of amlodipine compared to losartan in patients with mild to moderately severe hypertension.

Phillips RA, Kloner RA, Grimm RH Jr, Weinberger M.

J Clin Hypertens (Greenwich). 2003 Jan-Feb;5(1):17-23.

17.

A meta-analytical approach to the efficacy of antihypertensive drugs in reducing blood pressure.

Baguet JP, Robitail S, Boyer L, Debensason D, Auquier P.

Am J Cardiovasc Drugs. 2005;5(2):131-40.

PMID:
15725044
18.

Comparison of the efficacy and safety of fixed-dose amlodipine/losartan and losartan in hypertensive patients inadequately controlled with losartan: a randomized, double-blind, multicenter study.

Hong BK, Park CG, Kim KS, Yoon MH, Yoon HJ, Yoon JH, Yang JY, Choi YJ, Cho SY.

Am J Cardiovasc Drugs. 2012 Jun 1;12(3):189-95. doi: 10.2165/11597410-000000000-00000.

PMID:
22462558
19.

Drug-gene interactions between genetic polymorphisms and antihypertensive therapy.

Schelleman H, Stricker BH, De Boer A, Kroon AA, Verschuren MW, Van Duijn CM, Psaty BM, Klungel OH.

Drugs. 2004;64(16):1801-16. Review.

PMID:
15301563
20.

Target blood pressure attainment in diabetic hypertensive patients: need for more diuretics?

Sweileh WM.

Int J Clin Pharmacol Ther. 2009 Jul;47(7):434-8.

PMID:
19640349

Supplemental Content

Support Center